Inactive Instrument
Urovant Sciences Ltd. Stock
Stocks
UROV
BMG9381B1081
Biotechnology & Medical Research
| 1 day | +0.06% |
| Manager | Title | Age | Since |
|---|---|---|---|
James Robinson
CEO | Chief Executive Officer | 56 | 2020-03-22 |
Ajay Bansal
DFI | Director of Finance/CFO | 64 | 2019-10-27 |
| Chief Tech/Sci/R&D Officer | 68 | 2018-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sef P. Kurstjens
BRD | Director/Board Member | 62 | 2018-06-30 |
James Robinson
BRD | Director/Board Member | 56 | 2019-02-28 |
| Director/Board Member | 61 | 2019-12-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/29/21 | Issuer sale | Director | 111,480 | 0.3405% | ||
| 3/29/21 | Issuer sale | Director | 111,480 | 0.3405% | ||
| 3/29/21 | Issuer sale | Controller/Auditor | 286,031 | 0.8736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | +0.06% | - | - | 373M | |
| +4.35% | +16.60% | +58.11% | +95.21% | 62.53B | |
| +2.83% | -3.48% | +24.97% | +67.25% | 52.43B | |
| +0.91% | -0.83% | -17.01% | -13.43% | 23.1B | |
| +0.27% | -3.98% | -11.28% | +350.30% | 21.4B | |
| +2.36% | +8.20% | +29.35% | -6.73% | 21.17B | |
| +0.75% | +1.34% | +32.22% | -25.25% | 17.76B | |
| +9.88% | +23.61% | +222.87% | +385.49% | 15.47B | |
| +0.41% | +3.12% | +18.15% | +618.84% | 14.68B | |
| +1.25% | +2.48% | +51.36% | +179.72% | 14.08B | |
| Average | +2.18% | +4.45% | +45.42% | +183.49% | 26.96B | |
| Weighted average by Cap. | +2.71% | +5.40% | +40.96% | +138.71% |
Employees
-
